Growth
Reacta Healthcare: Feeding the future of food allergy diagnostics
- Growth
- Testimonial
- 5 minutes read
Reacta Healthcare manufactures food allergy diagnostics end-to-end - from R&D through to manufacturing and product release - out of a 23,000 square foot facility in North Wales. As an early-stage life sciences business, Reacta needed a banking partner that understands the realities of the sector and could open doors globally. Partnering with HSBC Innovation Banking brought practical support, deep expertise and a network that helped accelerate plans for international growth.
- End-to-end capability matters: Reacta manages R&D, manufacturing, and product release for its oral food challenge products from a 23,000-square-foot site in North Wales, complemented by recently added in-house analytics capabilities.
- Sector knowledge reduces friction: Working with a banking partner that understands life sciences helped the team focus on progress rather than constantly explaining the basics.
- Networks accelerate expansion: Global connections and on-the-ground introductions opened doors and shortened Reacta’s runway into Asia.
Reacta Healthcare: An appetite for success
Reacta Healthcare manufactures food allergy diagnostics.
Operating from a 23,000 square foot facility in North Wales, the team manages the full journey in-house: research and development right through to manufacturing and the release of products. In addition to their dedicated allergen suites, the facility also contains analytical labs.
It’s a growing business with impressive vertical capabilities, but the life science and healthcare space is one that is incredibly complex.
Life sciences businesses don’t just “scale”. They validate, document, test, and then scale, often while managing long timelines, specialised facilities and strict quality expectations.
And that demands deep sector expertise coupled with specialised banking solutions.
Reacta Healthcare and HSBC Innovation Banking
As a small, early-stage business with a bold vision, the Reacta team was looking for more than basic banking.
Chief Innovation Officer (CInO) Dr Martin Wickham points out that they needed a bank who could support their vision; a partner that understands the life sciences as an industry, but also the challenges of scaling in a highly competitive, regulated space.
Dr Martin Wickham, CInO, Reacta Healthcare"We needed a bank that could understand our needs and actually work with us. But from the moment we joined HSBC Innovation Banking it just felt like a huge weight was lifted off our shoulders."
In addition to understanding startup challenges, our team's deep sector knowledge is also something the team values.
Paul Abrahams, CEO, Reacta Healthcare"Our experience with HSBC Innovation Banking has been one of deep sector knowledge. Having an institution that understands how life sciences work, and the challenges of that industry, is invaluable."
Reacta Healthcare: Reaching new markets
Another business advantage of working with a truly global bank that has “connections on the ground right across the globe” is the ability to unlock new opportunities.
Reacta have experienced this first hand.
Our team invited Reacta to China, which spurred new thinking about exploring new markets, technologies and opportunities.
Dr Martin Wickham, CInO, Reacta Healthcare"The fact that they could introduce us to their network was really key for us. It’s definitely opened doors for us and shortened our runway into China."
Reacta Healthcare’s story is a reminder that scaling in life sciences is as much about execution as innovation. With end-to-end manufacturing capability and growing analytical strength, the business is building a platform for long-term impact in food allergy diagnostics.
Partnering with HSBC Innovation Banking provided sector expertise and a global network that helped turn international ambition, particularly in China, into actionable opportunity.
For early-stage teams, that combination of understanding, practicality and connectivity can feel like exactly what it is: a weight lifted, and momentum regained.
Any opinions expressed are merely opinions and not facts. All information in this document is for general informational purposes and not to be construed as professional advice or to create a professional relationship and the information is not intended as a substitute for professional advice. Nothing in this document takes into account your company’s individual circumstances. HSBC Innovation Banking does not make any representations or warranties with respect to the accuracy, applicability, fitness or completeness of this document and the material may not reflect the most current legal or regulatory developments. HSBC Innovation Banking disclaims all liability in respect to actions taken or not taken based on any or all of the contents in this document to the fullest extent permitted by law. Nothing relating to this material should be construed as a solicitation or offer, or recommendation, to acquire or dispose of any investment or to engage in any other transaction.
